共 4 条
抗肿瘤天然药物的研究概况
被引:20
作者:

杨静怡
论文数: 0 引用数: 0
h-index: 0
机构: 中国药科大学药学院药化教研室

论文数: 引用数:
h-index:
机构:

论文数: 引用数:
h-index:
机构:

论文数: 引用数:
h-index:
机构:
机构:
[1] 中国药科大学药学院药化教研室
来源:
关键词:
抗肿瘤;
天然产物;
衍生物;
D O I:
暂无
中图分类号:
R287 [各科用药];
学科分类号:
100810 [分子生药学];
摘要:
目的介绍近年来一些抗肿瘤天然药物的研究概况。方法综合最新国内外文献报道,总结抗肿瘤天然药物的研究近况。结果一些抗肿瘤天然药物及其衍生物的研究取得很大进展。结论从天然活性产物中寻找开发抗肿瘤新药具有重要意义。
引用
收藏
页码:277 / 282
页数:6
相关论文
共 4 条
[1]
The benzophenanthridine alkaloid fagaronine induces erythroleukemic cell differentiation by gene activation
[J].
Dupont, C
;
Couillerot, E
;
Gillet, R
;
Caron, C
;
Zeches-Hanrot, M
;
Riou, JFO
;
Trentesaux, C
.
PLANTA MEDICA,
2005, 71 (06)
:489-494

Dupont, C
论文数: 0 引用数: 0
h-index: 0
机构: Univ Reims, UFR Pharmacie, IFR 53 Biomol, JE 2428 Onco Pharmacol, F-51096 Reims, France

Couillerot, E
论文数: 0 引用数: 0
h-index: 0
机构: Univ Reims, UFR Pharmacie, IFR 53 Biomol, JE 2428 Onco Pharmacol, F-51096 Reims, France

Gillet, R
论文数: 0 引用数: 0
h-index: 0
机构: Univ Reims, UFR Pharmacie, IFR 53 Biomol, JE 2428 Onco Pharmacol, F-51096 Reims, France

Caron, C
论文数: 0 引用数: 0
h-index: 0
机构: Univ Reims, UFR Pharmacie, IFR 53 Biomol, JE 2428 Onco Pharmacol, F-51096 Reims, France

Zeches-Hanrot, M
论文数: 0 引用数: 0
h-index: 0
机构: Univ Reims, UFR Pharmacie, IFR 53 Biomol, JE 2428 Onco Pharmacol, F-51096 Reims, France

Riou, JFO
论文数: 0 引用数: 0
h-index: 0
机构: Univ Reims, UFR Pharmacie, IFR 53 Biomol, JE 2428 Onco Pharmacol, F-51096 Reims, France

Trentesaux, C
论文数: 0 引用数: 0
h-index: 0
机构: Univ Reims, UFR Pharmacie, IFR 53 Biomol, JE 2428 Onco Pharmacol, F-51096 Reims, France
[2]
A phase II study of liposomal lurtotecan (OSI-211) in patients with topotecan resistant ovarian cancer
[J].
Seiden, MV
;
Muggia, F
;
Astrow, A
;
Matulonis, U
;
Campos, S
;
Roche, M
;
Sivret, J
;
Rusk, J
;
Barrett, E
.
GYNECOLOGIC ONCOLOGY,
2004, 93 (01)
:229-232

Seiden, MV
论文数: 0 引用数: 0
h-index: 0
机构: Massachusetts Gen Hosp, Gillete Ctr Womens Canc, Div Hematol Oncol, Boston, MA 02114 USA

Muggia, F
论文数: 0 引用数: 0
h-index: 0
机构: Massachusetts Gen Hosp, Gillete Ctr Womens Canc, Div Hematol Oncol, Boston, MA 02114 USA

Astrow, A
论文数: 0 引用数: 0
h-index: 0
机构: Massachusetts Gen Hosp, Gillete Ctr Womens Canc, Div Hematol Oncol, Boston, MA 02114 USA

Matulonis, U
论文数: 0 引用数: 0
h-index: 0
机构: Massachusetts Gen Hosp, Gillete Ctr Womens Canc, Div Hematol Oncol, Boston, MA 02114 USA

论文数: 引用数:
h-index:
机构:

Roche, M
论文数: 0 引用数: 0
h-index: 0
机构: Massachusetts Gen Hosp, Gillete Ctr Womens Canc, Div Hematol Oncol, Boston, MA 02114 USA

Sivret, J
论文数: 0 引用数: 0
h-index: 0
机构: Massachusetts Gen Hosp, Gillete Ctr Womens Canc, Div Hematol Oncol, Boston, MA 02114 USA

Rusk, J
论文数: 0 引用数: 0
h-index: 0
机构: Massachusetts Gen Hosp, Gillete Ctr Womens Canc, Div Hematol Oncol, Boston, MA 02114 USA

Barrett, E
论文数: 0 引用数: 0
h-index: 0
机构: Massachusetts Gen Hosp, Gillete Ctr Womens Canc, Div Hematol Oncol, Boston, MA 02114 USA
[3]
Inhibitors of ABC-type drug efflux pumps: an overview of the current patent situation
[J].
Chiba, P
;
Ecker, GF
.
EXPERT OPINION ON THERAPEUTIC PATENTS,
2004, 14 (04)
:499-508

Chiba, P
论文数: 0 引用数: 0
h-index: 0
机构: Univ Vienna, Dept Pharmaceut Chem, A-1090 Vienna, Austria

Ecker, GF
论文数: 0 引用数: 0
h-index: 0
机构: Univ Vienna, Dept Pharmaceut Chem, A-1090 Vienna, Austria
[4]
The discovery of BMS-275183: An orally efficacious novel taxane
[J].
Mastalerz, H
;
Cook, D
;
Fairchild, CR
;
Hansel, S
;
Johnson, W
;
Kadow, JF
;
Long, BH
;
Rose, WC
;
Tarrant, J
;
Wu, MJ
;
May, QF
;
Zhang, GF
;
Zoeckler, M
;
Vyas, DM
.
BIOORGANIC & MEDICINAL CHEMISTRY,
2003, 11 (20)
:4315-4323

Mastalerz, H
论文数: 0 引用数: 0
h-index: 0
机构: Bristol Myers Squibb Co, Pharmaceut Res Inst, Discovery Chem, Wallingford, CT 06492 USA

Cook, D
论文数: 0 引用数: 0
h-index: 0
机构: Bristol Myers Squibb Co, Pharmaceut Res Inst, Discovery Chem, Wallingford, CT 06492 USA

Fairchild, CR
论文数: 0 引用数: 0
h-index: 0
机构: Bristol Myers Squibb Co, Pharmaceut Res Inst, Discovery Chem, Wallingford, CT 06492 USA

Hansel, S
论文数: 0 引用数: 0
h-index: 0
机构: Bristol Myers Squibb Co, Pharmaceut Res Inst, Discovery Chem, Wallingford, CT 06492 USA

Johnson, W
论文数: 0 引用数: 0
h-index: 0
机构: Bristol Myers Squibb Co, Pharmaceut Res Inst, Discovery Chem, Wallingford, CT 06492 USA

Kadow, JF
论文数: 0 引用数: 0
h-index: 0
机构: Bristol Myers Squibb Co, Pharmaceut Res Inst, Discovery Chem, Wallingford, CT 06492 USA

Long, BH
论文数: 0 引用数: 0
h-index: 0
机构: Bristol Myers Squibb Co, Pharmaceut Res Inst, Discovery Chem, Wallingford, CT 06492 USA

Rose, WC
论文数: 0 引用数: 0
h-index: 0
机构: Bristol Myers Squibb Co, Pharmaceut Res Inst, Discovery Chem, Wallingford, CT 06492 USA

Tarrant, J
论文数: 0 引用数: 0
h-index: 0
机构: Bristol Myers Squibb Co, Pharmaceut Res Inst, Discovery Chem, Wallingford, CT 06492 USA

Wu, MJ
论文数: 0 引用数: 0
h-index: 0
机构: Bristol Myers Squibb Co, Pharmaceut Res Inst, Discovery Chem, Wallingford, CT 06492 USA

May, QF
论文数: 0 引用数: 0
h-index: 0
机构: Bristol Myers Squibb Co, Pharmaceut Res Inst, Discovery Chem, Wallingford, CT 06492 USA

Zhang, GF
论文数: 0 引用数: 0
h-index: 0
机构: Bristol Myers Squibb Co, Pharmaceut Res Inst, Discovery Chem, Wallingford, CT 06492 USA

Zoeckler, M
论文数: 0 引用数: 0
h-index: 0
机构: Bristol Myers Squibb Co, Pharmaceut Res Inst, Discovery Chem, Wallingford, CT 06492 USA

Vyas, DM
论文数: 0 引用数: 0
h-index: 0
机构: Bristol Myers Squibb Co, Pharmaceut Res Inst, Discovery Chem, Wallingford, CT 06492 USA
